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Purpose: Postoperative ileus (POI) is common following bowel resection for radi-
cal cystectomy with ileal conduit (RCIC). We investigated perioperative factors as-
sociated with prolonged POI following RCIC, with specific focus on opioid-based 
analgesic dosage. Materials and Methods: From March 2007 to January 2013, 78 
open RCICs and 26 robot-assisted RCICs performed for bladder carcinoma were 
identified with adjustment for age, gender, American Society of Anesthesiologists 
grade, and body mass index (BMI). Perioperative records including operative time, 
intraoperative fluid excess, estimated blood loss, lymph node yield, and opioid anal-
gesic dose were obtained to assess their associations with time to passage of flatus, 
tolerable oral diet, and length of hospital stay (LOS). Prior to general anaesthesia, 
patients received epidural patient-controlled analgesia (PCA) consisted of fentanyl 
with its dose adjusted for BMI. Postoperatively, single intravenous injections of tra-
madol were applied according to patient desire. Results: Multivariate analyses re-
vealed cumulative dosages of both PCA fentanyl and tramadol injections as inde-
pendent predictors of POI. According to surgical modality, linear regression 
analyses revealed cumulative dosages of PCA fentanyl and tramadol injections to 
be positively associated with time to first passage of flatus, tolerable diet, and LOS 
in the open RCIC group. In the robot-assisted RCIC group, only tramadol dose was 
associated with time to flatus and tolerable diet. Compared to open RCIC, robot-as-
sisted RCIC yielded shorter days to diet and LOS; however, it failed to shorten days 
to first flatus. Conclusion: Reducing opioid-based analgesics shortens the duration 
of POI. The utilization of the robotic system may confer additional benefit.
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INTRODUCTION
Postoperative ileus (POI) is a transient impairment of bowel motility related to sur-
gical trauma and associated physiological responses.1 The urologic procedure with 
which POI is most commonly associated is radical cystectomy (RC) wherein a por-
tion of the small bowel, usually the ileum, is resected and utilized as a urinary con-
duit. Prolonged POI is associated with nausea, vomiting, delayed oral intake, in-
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gery, neoadjuvant or adjuvant chemotherapy, or exposure to 
pelvic radiotherapy were excluded from the study.
Operative technique and postoperative care
For all patients, our institution used a collaborative clinical 
care pathway following RCIC. Prior to general anaesthesia, 
epidural patient-controlled analgesia (PCA) was applied 
which was consisted of fentanyl, a lipophilic opioid. The to-
tal dose of fentanyl was adjusted according to BMI, with epi-
dural infusion rates set at 10--12 μg/h to provide continuous 
delivery for a period of 72 hrs. RCICs were performed in a 
standardized manner for pelvic lymph node dissection. Ro-
botic RCICs were performed with a single 12 mm camera 
trocar; three 8 mm robotic trocars and a 12 mm and a 5 mm 
assistant trocar with urinary diversions operated extracorpo-
really. Open RCIC was performed through an infraumbili-
cal incision. Following surgery, all patients were placed on a 
standard post-cystectomy care plan including early ambula-
tion, placement of nasogastric decompression tubes until 
the first passage of flatus, and single intravenous injection 
of 50 mg of tramadol applied according to patient desires. 
Initiation of diet began after the first passage of flatus and 
after confirming tolerance to sips of water. The time to diet 
toleration was defined as the first day of consecutive oral 
consumption until discharge without signs of abdominal 
distension, nausea, or emesis.
Outcome measures
The primary outcome was to investigate perioperative fac-
tors associated with prolonged duration of POI in terms of 
time to first flatus, tolerable oral diet, and LOS. For multi-
variate logistic regression analyses, POI was defined as an 
absence of passage of flatus by 5 postoperative days.5 Intra-
operative factors measured included operative time (inci-
sion to closure), EBL, excessive intraoperative fluid over-
load, LN yield, and surgical modality (i.e., open versus robot-
assisted technique). Postoperative factors examined included 
the total dosage of PCA fentanyl and cumulative dosages of 
tramadol within the first five days after surgery. All out-
come measures were obtained retrospectively.
Statistical analyses
Demographic and baseline data were summarized using pro-
portions and medians where appropriate. The χ2-test was 
used to evaluate associations between categorical variables, 
and the Mann-Whitney U test was used for continuous vari-
ables. Liner regression analyses were performed to identify 
creased postoperative morbidity, and length of hospital stay 
(LOS) and, thus, increased medical expenditure.2 Therefore, 
minimizing the duration of POI is a desirable aim for all 
healthcare services.
The mechanisms underlying POI are known to be com-
plex. Increasing age, body mass index (BMI), operative 
time, blood loss, activation of inhibitory reflexes, inflamma-
tory mediators, and both endogenous and exogenous opioids 
are thought to be contributing factors to prolonged POI.3 Al-
though it is not possible to completely eradicate POI, strate-
gies have been explored to shorten its duration. These in-
clude minimally invasive surgery, reduction of opioids, 
prokinetic agents, early mobilization, enteric feeding, and 
epidural anaesthesia, all of which require cooperation of the 
entire surgical and anaesthesiology team.4 Considerable ad-
vancements in this field of research have led to substantial 
reductions in POI; however, considering that POI is the most 
serious burden for patients following radical cystectomy with 
ileal conduit (RCIC), additional investigations are needed to 
understand the underlying multifactorial mechanisms and to 
further improve rehabilitation of bowel function.
The purpose of the current study was to examine whether 
factors could be identified that predict the prolongation of 
POI following RCIC with a specific focus on pharmacolog-
ical analgesic regimens and perioperative determinants dur-
ing routine RCIC care regimens. Our results suggest that 
duration of POI following RCIC depends on multiple caus-
ative factors; some factors are modifiable during the reha-





From our prospective bladder cancer database, 196 patients 
who underwent RCIC between March 2007 and January 
2013 were identified. Among them, 78 (75%) open RCICs 
and 26 (25%) robot-assisted RCICs were identified with ad-
justment for age, gender, American Society of Anesthesiolo-
gists (ASA) grade, and BMI. Patient demographics and 
perioperative records including operative time, intraoperative 
positive intravenous (IV) fluid balance, estimated blood loss 
(EBL), lymph node (LN) yield, and opioid analgesic dose 
were retrospectively obtained to assess their associations 
with time to first passage of flatus, tolerable oral diet, and 
LOS. Patients who had previous histories of abdominal sur-
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shorter LOS.
Multivariate logistic regression analysis incorporating pa-
tient age, gender, ASA grade, BMI, EBL, intraoperative 
positive IV fluid balance, operative time, and cumulative 
dosages of fentanyl and tramadol, demonstrated that both 
fentanyl and tramadol dosages were associated with an in-
creased risk of POI (Table 2). Multiple linear regression 
analysis was performed to investigate the dose-response re-
lationship between studied determinants and bowel recov-
ery indices (Table 3). For the overall cohort, age, gender, 
ASA grade, BMI, EBL, intraoperative positive IV fluid bal-
ance, LN yield, and operative time had no associations with 
the duration of POI. However, the total dosages of fentanyl 
and tramadol revealed significant positive associations with 
time to flatus, tolerance to diet, and LOS. 
Effects of fentanyl and tramadol dosages were investigat-
ed according to each surgical modality and are presented in 
Table 4. In the open RCIC group, both fentanyl and trama-
dol doses were significantly positively associated with all 
bowel recovery indices. In the robotic RCIC group, only 
tramadol dosage had a significant positive association with 
time to first flatus and oral diet. Perioperative factors in-
cluding EBL, positive IV fluid balance, LN yield, and oper-
ative time did not show any associations with bowel recov-
ery indices for either surgical modality (data not shown; 
p>0.05).
factors associated with the duration of bowel recovery indi-
ces. Univariate and multivariate analyses were performed ac-
cording to logistic regression models. Variables considered 
as potential predictors for multivariate modeling were se-
lected by univariate analyses and subsequently tested in a 
stepwise forward conditional manner with entry and reten-
tion in the model set at a significance level of 0.05. All re-
ported p-values were two-sided with statistical significance 
set at p<0.05. All analyses were performed using SPSS ver-




Patient demographics and perioperative data according to 
surgical modality are shown in Table 1. Comparisons of 
gender, age, ASA grade, and BMI confirmed appropriate 
cohort matching. Compared to the open RCIC group, the 
robot-assisted RCIC group experienced less EBL and short-
er times to tolerable oral diet and LOS, even though extents 
of surgery were wider, as shown by higher LN yields. Total 
infused doses of fentanyl and tramadol were comparable 
between the two surgical groups. Mean operative time and 
time to first passage of flatus were not significantly differ-
ent between the groups. However, utilization of the robotic-
system resulted in significantly shorter time to diet and 
Table 1. Patient Demographics and Perioperative Characteristics According to Surgical Modality
Open RCIC (n=78) Robot-assisted RCIC (n=26) p value
Sex (n, %) 0.436
    Male      59 (85.5)      22 (84.6)
    Female      10 (14.5)        4 (15.4)
Age (yrs)   66.7 (62.7--72.5)   65.2 (59.5--72.1) 0.437
ASA grade (n, %) 0.841
    1      12 (17)        5 (19)
    2      57 (83)      21 (81)
BMI (kg/m2)   22.9 (20.3--25.4)   22.4 (20.4--25.1) 0.663
Operative time (mins) 428.3 (360.1--480.0) 414.1 (341.5--461.5) 0.486
Intraoperative fluid overload (mL)  3418 (2700--4125)  2661 (2138--2950) <0.001
EBL (mL)  1300 (800--1650) 549.6 (300--600) <0.001
LN yield (n)   14.1 (8.5--17.5)   18.6 (12.8--22.3) 0.028
Total infused PCA fentanyl* 115.4 (85--135)    120 (90--145) 0.196
Total infused tramadol*   71.2 (50--95)   65.4 (45--80) 0.349
Days to passage of flatus     4.9 (4--6)     4.3 (3--5) 0.051
Days to tolerable oral diet     7.8 (6--9)     5.5 (4--6) <0.001
LOS (days)   14.8 (12--17.5)   11.2 (9.5--12.5) <0.001
ASA, American Society of Anesthesiologists; BMI, body mass index; EBL, estimated blood loss; LN, lymph node; LOS, length of hospital stay; RCIC, radical 
cystectomy with ileal conduit; PCA, patient-controlled analgesia; IQR, interquartile range.
Values are given as median (IQR).
*Doses are expressed in morphine-equivalents.
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cations-including surgical site infection, pelvic lymphocele 
formation, and anastomosis leakage-POI is the most com-
mon, occurring at a rate anywhere from 1.58% to 25.5%.6 
The etiology of POI is complex. It is primarily associated 
with surgical stress, as it is an acute inflammatory response 
to manipulation of the bowel during surgery wherein endog-
enous opioids are secreted through the gastrointestinal (GI) 
tract in response to surgical trauma.7 Recent advancements 
in anaesthetic and surgical techniques have led to substan-
DISCUSSION
RC with pelvic lymph node dissection is the standard treat-
ment for muscle-invasive bladder cancer and yields a 10-year 
recurrence-free survival rate of 50--59%; overall survival 
rates are approximately 45%.6 RCIC is a technically chal-
lenging procedure, after which patients often face uncertain 
postoperative courses. Among various postoperative compli-
Table 2. Univariate and Multivariate Logistic Regression Analyses of Prognostic Factors in Relation to Postoperative Ileus, 
Defined as an Absence of Passage of Flatus by 5 Postoperative Days
Variables
Univariate analysis Multivariate analysis*
OR (95% CI) p value OR (95% CI) p value
Patient demographics
    Age 1.013 (0.972--1.055) 0.555
    Sex
        Female 1 (Reference)
        Male 1.958 (0.441--8.708) 0.377
    BMI 1.001 (0.881--1.139) 0.983
Perioperative determinants
    Surgical modality
        Open 1 (Reference)
        Robot-assisted 0.564 (0.227--1.404) 0.219
    EBL 1.001 (1.000--1.001) 0.131
    Operative time 1.003 (0.999--1.007) 0.127
    Positive IV fluid balance 1.000 (1.000--1.001) 0.138
Postoperative analgesic dose
    PCA fentanyl 1.003 (1.001--1.004) 0.001 1.003 (1.001--1.004) 0.014
    IV tramadol 1.333 (1.109--1.602) 0.002 1.278 (1.049--1.556) 0.015
OR, odds ratio; BMI, body mass index; EBL, estimated blood loss; PCA, patient-controlled analgesia; IV, intravenous; CI, confidence interval.
*Forward step-wise conditional method.
Table 3. Multiple Linear Regression Analyses for Bowel Recovery Indices Following Open Radical Cystectomy with Ileal Con-
duit According to Patient Demographics and Perioperative Determinants
Time to first flatus Time to tolerable oral diet LOS
β p value β p value β p value
Patient demographics
    Age 1.31 0.134 1.89 0.064 1.64 0.106
    Sex 0.14 0.892 0.05 0.961 -0.16 0.873
    BMI -1.66 0.103 -1.03 0.308 -1.09 0.279
Perioperative determinants
    EBL 1.71 0.092 1.12 0.121 1.69 0.068
    Operative time 1.04 0.304 1.76 0.083 0.55 0.582
    Positive IV fluid balance 1.22 0.142 -0.41 0.688 0.93 0.354
    LN yield 0.19 0.854 -1.19 0.239 -0.78 0.441
Postoperative analgesic dose
    PCA fentanyl dose 4.19 <0.001 4.09 <0.001 3.49 0.002
    IV tramadol dose 3.28 0.041 2.53 0.015 3.06 0.004
IV, intravenous; PCA, patient controlled anesthesia; LOS, length of hospital stay; BMI, body mass index; EBL, estimated blood loss; LN, lymph node.
Time to first flatus model: F value=6.994 (p<0.001), R2=0.707. Time to tolerable diet model: F value=7.409 (p<0.001), R2=0.693. LOS model: F value=6.138 
(p<0.001), R2=0.665.
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sponse relationship with the duration of POI. Opioids di-
rectly act on cerebral and spinal μ-opioid receptors at the 
level of the myenteric plexus to suppress pain transmis-
sion.8 Opioid-based analgesia is currently the standard of 
care for the management of perioperative pain after major 
bowel surgeries due to their strong analgesic effect. At the 
same time, however, opioids act on peripheral μ-opioid re-
ceptors in the GI tract, resulting in disruptions of the mi-
grating motor complex and propulsive motor activity asso-
ciated with GI motility, thereby exacerbating POI.2,7 The 
exacerbation of bowel dysfunction is one of the most dis-
tressing side effects of opioids, which restricts their use.
Our study revealed a dose-dependent association between 
opioid dose and duration of POI following RCIC. This as-
sociation could be explained by the assumption that the ef-
fect of epidural administration of opioids is mediated not 
only by a local effect on spinal μ-opioid receptors, but also 
tial reductions in convalescence and LOS after major GI 
surgeries. To gain further insight into how treatment regi-
mens affect bowel recovery following RCIC, components of 
our institutional rehabilitation program including pharma-
cologic, anaesthetic, and surgical modality regimens were 
collected and investigated. Observations of our study as-
sumed a dose-response relationship between postoperative 
opioid-based analgesics and bowel recovery time. The re-
sult that robotic RCIC quickened bowel recovery lends fur-
ther support to the notion that decreased handling and expo-
sure of the intestines and less manipulation of the abdominal 
wall are strong factors in reducing the duration of POI.2
Opioid effects in the prolongation of POI
Our results revealed that the total doses of fentanyl and tra-
madol each converted into morphine equivalents were not 
only independent predictors of POI, but also had a dose-re-
Table 4. Effects of PCA Fentanyl and IV Tramadol Dosages According to Surgical Modality
PCA fentanyl dose IV tramadol dose
β p value β p value
Open RCIC
    Time to first flatus 5.048 <0.001 2.095 0.041
    Time to tolerable oral diet 4.093 <0.001 2.526 0.015
    LOS 3.493 0.001 3.063 0.004
Robotic RCIC
    Time to first flatus -0.127 0.911 3.689 0.001
    Time to tolerable oral diet 0.534 0.599 4.04 <0.001
    LOS -1.308 0.203 0.439 0.665
PCA, patient controlled anesthesia; IV, intravenous; RCIC, radical cystectomy with ileal conduit; LOS, length of hospital stay.
PCA fentanyl dose model: F value=3.208 (p=0.023), R2=0.662. IV tramadol dose model: F value=2.639 (p=0.047), R2=0.754.
Table 5. Comparison of Reports of Bowel Recovery Indexes Following Radical Cystectomy with Ileal Conduit
Citation
No. of cases 
(open:robot)
Bowel recovery index (D) Open Robotic* p value
Wang, et al.13 21:33
Time to diet   5   4 0.002
Time to LOS   8   5 0.007
Pruthi and Wallen14 24:20
Time to flatus   2.1   2.9 <0.001
Time to bowel movement   2.8   3.8 <0.001
Time to LOS   4.4   5.3 0.007
Nix, et al.15 20:21
Time to flatus   3.2   2.3 0.001
Time to bowel movement   4.3   3.2 0.001
Time to LOS   6   5.1 0.239
Knox, et al.16 84:58
Time to flatus   5.9   4.3 0.028
Time to diet   8.1   5.4 0.009
Time to LOS 10.8   6.3 0.004
Rha, et al.
  (current study)
78:26
Time to flatus   4.9   4.3 0.051
Time to diet   7.8   5.5 <0.001
Time to LOS 14.8 11.2 <0.001
RCIC, radical cystectomy with ileal conduit; LOS, length of hospital stay.
*Extracorporeal urinary diversions performed in all robotic RCICs.
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cytokine cascades, including a pivotal role for tumour ne-
crosis factor-α and interleukin-1β, are also known to con-
tribute to inflammatory responses, which cause intestinal 
smooth muscle dysfunction.20
Significance of alternative strategies in reducing the 
duration of POI
A series of strategies to reduce the duration of POI that had 
been proposed in previous studies did not show significant 
correlations in our study. First, there was no significant ef-
fect of minimizing perioperative fluid excess to prevent in-
testinal edema, even though restricting intraoperative fluid 
was shown to significantly reduce POI in patients undergo-
ing colonic surgery.21 Accordingly, patients who received lib-
eral amounts of fluids had a significantly longer time to first 
passage of flatus.22 In our study, intraoperative positive fluid 
balance was correlated with time to tolerable diet (r=0.278, 
p=0.032) and LOS (r=0.352, p=0.002); however, the corre-
lation coefficients were too low to be considered signifi-
cant. Second, high EBL has been shown to be a predictor 
for paralytic ileus.6 In our study, however, EBL showed no 
significant associations. Third, preoperatively higher ASA 
score, older age, and female gender are widely accepted de-
terminants that affect prolongation of POI.3,6 Therefore, we 
considered these factors as confounders and adjusted for 
them when selecting our cases, supporting the idea that oth-
er determinant factors should be weighed based on relative 
importance rather than being assigned equal weights. Last-
ly, performing intracorporeal rather than extracorporeal uri-
nary diversions has been suggested to quicken bowel re-
covery by reducing unnecessary fluid loss from the bowels, 
thus preventing electrolyte imbalance.23 However, compari-
son studies between both procedures have so far failed to 
show a benefit of intracorporeal urinary diversions in terms 
of bowel recovery.24
The retrospective nature and the selective bias inherent in 
surgical studies are limitations of this study. Although pa-
tients of the open RCIC group were selected upon adjust-
ment of confounding factors, there were patients who were 
not considered as candidates for cystectomy due to comor-
bidities. Urologists should set an evidence-based consensus 
upon the management of this complex issue, considering 
that POI is an entity which depends not only on the hands 
of the surgeon, but also on multiple other factors.
POI has long been thought to be an obligatory response 
following bowel surgery; however, evidence indicates that 
multimodal rehabilitation strategies may reduce the duration 
by therapeutic serum levels achieved after systemic absorp-
tion and distribution of opioid.9 An indirect effect of opioids 
on bowel dysfunction has been experimentally studied by 
Topcu, et al.,10 who showed that inflammation sensitizes 
opioid receptors in the myenteric and submucosal plexus as 
well as in the peripheral and central terminals to increase 
effects of exogenously administered opioids. Whereas in-
testinal inflammation is known to increase pharmacologic 
effects of opioids by 1.9-fold, bowel resection and re-anas-
tomosis as in RCIC may lend further weight to the evi-
dence of this adverse effect.11
Tramadol, a synthetic analogue of codeine, is a centrally 
acting analgesic with a low affinity for μ-opioid receptors.10 
Nevertheless, studies found that tramadol also has a dose-
dependent prolonging effect on colonic transit time, although 
the effect is relatively small compared to other opioids.12 Our 
study confirmed that cumulative dose of tramadol is a con-
tributing factor to POI, and that minimizing its dosage, in 
consideration of pain degree, could be a promising strategy 
for patients with prolonged bowel recovery.
Utilization of minimally-invasive surgical techniques to 
reduce the duration of POI
Utilization of the robotic system provided significant reduc-
tions of duration to tolerable oral diet and LOS compared to 
the open technique. Our results in Asian men are in part 
consistent with previous studies with Western men in which 
the duration of POI was significantly reduced by robotic 
surgery compared to the open technique (Table 5).13-16 Sev-
eral mechanisms are suggested. First, the duration of POI 
has been shown to correlate with the degree of surgical trau-
ma.3 Activation of inhibitory reflexes in the afferent limbs 
originating from the incision (somatic fibers) as well as 
from intestines (visceral fibers) have been proposed to be 
one of the underlying mechanisms in the development of 
POI.17 This stress response, which inhibits GI motility, is at-
tributed to increases in the release of cytokines and catechol-
amines, e.g., norepinephrine.18 Second, excessive manipula-
tion of the intestines has been reported as a pathogenic 
factor in the development of POI.17 This is thought to be the 
result of activation of resident immune cells, particularly 
macrophages, and the recruitment of circulating leukocytes 
to the bowel wall.17 Excessive manipulation of the bowel 
during surgery has been shown to increase mucosal permea-
bility, resulting in endogenous bacterial products which act 
synergistically with this inflammatory process.19 In conjunc-
tion with these mechanisms, secretion of prostaglandins and 
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53:340-50.
12. Wilder-Smith CH, Hill L, Spargo K, Kalla A. Treatment of severe 
pain from osteoarthritis with slow-release tramadol or dihydroco-
deine in combination with NSAID’s: a randomised study compar-
ing analgesia, antinociception and gastrointestinal effects. Pain 
2001;91:23-31.
13. Wang GJ, Barocas DA, Raman JD, Scherr DS. Robotic vs open 
radical cystectomy: prospective comparison of perioperative out-
comes and pathological measures of early oncological efficacy. 
BJU Int 2008;101:89-93.
14. Pruthi RS, Wallen EM. Robotic assisted laparoscopic radical cys-
toprostatectomy: operative and pathological outcomes. J Urol 
2007;178(3 Pt 1):814-8. 
15. Nix J, Smith A, Kurpad R, Nielsen ME, Wallen EM, Pruthi RS. 
Prospective randomized controlled trial of robotic versus open 
radical cystectomy for bladder cancer: perioperative and patholog-
ic results. Eur Urol 2010;57:196-201. 
16. Knox ML, El-Galley R, Busby JE. Robotic versus open radical 
cystectomy: identification of patients who benefit from the robotic 
approach. J Endourol 2013;27:40-4.
17. Kehlet H, Holte K. Review of postoperative ileus. Am J Surg 
2001;182:3-10.
18. Steinbrook RA. An opioid antagonist for postoperative ileus. N 
Engl J Med 2001;345:988-9.
19. Schwarz NT, Beer-Stolz D, Simmons RL, Bauer AJ. Pathogenesis 
of paralytic ileus: intestinal manipulation opens a transient path-
way between the intestinal lumen and the leukocytic infiltrate of 
the jejunal muscularis. Ann Surg 2002;235:31-40.
20. Korolkiewicz RP, Ujda M, Dabkowski J, Ruczyński J, Rekowski 
P, Petrusewicz J. Differential salutary effects of nonselective and 
selective COX-2 inhibitors in postoperative ileus in rats. J Surg 
Res 2003;109:161-9.
21. Lobo DN, Bostock KA, Neal KR, Perkins AC, Rowlands BJ, Al-
lison SP. Effect of salt and water balance on recovery of gastroin-
testinal function after elective colonic resection: a randomised 
controlled trial. Lancet 2002;359:1812-8.
22. Nisanevich V, Felsenstein I, Almogy G, Weissman C, Einav S, 
Matot I. Effect of intraoperative fluid management on outcome af-
ter intraabdominal surgery. Anesthesiology 2005;103:25-32.
23. Canda AE, Atmaca AF, Altinova S, Akbulut Z, Balbay MD. Ro-
bot-assisted nerve-sparing radical cystectomy with bilateral ex-
tended pelvic lymph node dissection (PLND) and intracorporeal 
urinary diversion for bladder cancer: initial experience in 27 cases. 
BJU Int 2012;110:434-44.
24. Goh AC, Gill IS, Lee DJ, de Castro Abreu AL, Fairey AS, Leslie 
S, et al. Robotic intracorporeal orthotopic ileal neobladder: repli-
cating open surgical principles. Eur Urol 2012;62:891-901.
of POI. In our study, utilization of the robotic system was 
found to be a feasible option for shortening the time to POI 
recovery. Moreover, minimizing the dosage of opioid-based 
analgesics was observed to confer additional benefit in fur-
ther shortening the duration of POI following both open 
and robot-assisted RCICs.
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